CHANGES IN ARTERIAL STIFFNESS AND ENDOTHELIAL DYSFUNCTION ON THE BACKGROUND OF ANTICOAGULANT THERAPY AFTER CARDIOEMBOLIC STROKE IN PATIENTS WITH ATRIAL FIBRILLATION


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The present study is devoted to the evaluation of the effect of anticoagulant therapy with apixaban on the parameters of arterial stiffness and endothelial dysfunction (ED) in patients with atrial fibrillation (AF) who have experienced cardioembolic stroke (CES). The study included patients with a persistent or paroxysmal form of non-valvular AF who have experienced stroke and were discharged from Samara ’s vascular centers for follow-up. Patients were divided into 2 groups: 56 patients (Group 1) has received apixaban in a daily dose of 5 mg according to the recommendations. The comparison group (Group 2) included 57patients who did not follow the recommendations for taking anticoagulants. The duration of follow-up was 182.5±5.5 days. All the examinations were carried out during the period of sinus rhythm in patients: volume sphygmography, echocardiography and tissue dopplerography, analysis of ED (von Willebrand factor, tissue plasminogen activator-1 inhibitor, antithrombin III) .The results obtained indicate that arterial stiffness and endothelial function in patients with AF who have experienced CES have a positive tendency to improve against the background of anticoagulant therapy with apixaban.

Full Text

Restricted Access

About the authors

I. A Zolotovskaya

FSBEI HE "Samara State Medical University" of RMH

Email: zolotovskay@list.ru
PhD, Teaching Assistant at the Department of Hospital Therapy with courses of Policlinic Therapy and Transfusiology

I. L Davydkin

FSBEI HE "Samara State Medical University" of RMH

References

  1. Татарский Б.А., Баталов Р.Е., Попов С.В. Фибрилляция предсердий: патофизиологические подходы к выбору антиаритмической терапии. Томск, 2013. 484 с.
  2. Camm J.A., Singer D.E. Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke prevention Strategies based on Atrial Fibrillation information from implanted devices). Eur. Heart J. 2014;35(8):508-16.
  3. Zoni-Berisso M., Lercari F., Carazza T., Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clin. Epidemiol. 2014;6:213-20.
  4. January C.T/, Wann L.S., Alpert J.S., Calkins H., Cigarroa J.E., Cleveland J.C.Jr, Conti J.B., Ellinor P.T., Ezekowitz M.D., Field M.E., Murray K.T., Sacco R.L., Stevenson W.G., Tchou P.J., Tracy C.M., Yancy C.W. ACC/AHA Task Force Members. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014;130: 2071-104.
  5. Kirchhof P., Benussi S., Kotecha D., et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur. Heart J. 2016;37(38):2893-962.
  6. Chen L.Y., Foo D.C., Wong R.C., Seow S.C., Gong L., Benditt D.G., Ling L.H. Increased carotid intima-media hickness and arterial stiffness are associated with lone atrial fibrillation. Int. J. Cardiol. 2013;168:3132-34.
  7. Larstorp A.C.K., Ariansen I., Gjesdal K., Olsen M.H., Ibsen H., Devereux R.B., Okin P.M., Dahlöf B., Kjeldsen S.E., Wachtell K. Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy the losartan intervention for endpoint (LIFE) reduction in hypertension study. Hypertension. 2012;60:347-53.
  8. Proietti M., Calvieri C., Malatino L., Signorelli S., Corazza G.R., Perticone F., Vestri A.R., Loffredo L., Davl G., Violi F., Basili S. Relationship between carotid intima-media thickness and non valvular atrial fibrillation type. Atherosclerosis. 2015;238:350-55.
  9. Chou C.C., Chen P.S. New concepts in atrial fi brillation:neural mechanisms and calcium dynamics. Cardiol. Clin. 2009;27:35-43.
  10. Shen M.J., Choi E.K., Tan A.Y., Lin S.F., Fishbein M.C., Chen L.S., Chen P.S. Neural mechanisms of atria arrhythmias. Nat. Rev. Cardiol. 2012;9:30-9.
  11. Болевич С.Б., Войнов В.А. Молекулярные механизмы в патологии человека: Руководство для врачей. М., 2012.
  12. Cremer A., Lainé M., Papaioannou G., Yeim S., Gosse P. Increased arterial stiffness is an independent predictor of atrial fi brillation in hypertensive patients. J. Hypertens. 2015;33(1):2150-55.
  13. Shi D., Meng Q., Zhou X., Li L., Liu K., He S.,Wang S., Chen X. Factors infl uencing the relationship between atrial fi brillation and artery stiffness in elderly Chinese patients with hypertension. Aging. Clin. Exp. Res. 2016;28:638-53.
  14. Золотовская И.А., Давыдкин И.Л. Жесткость артерий в аспекте развития тромбоэмболических осложнений у лиц пожилого возраста с фибрилляцией предсердий. Успехи геронтологии. 2016;29:602-8.
  15. Gronewold J., Hermann D.M., Lehmann N., Kröger K., Lauterbach K., Berger K., Weimar C., Kälsch H.I., Moebus S., Jöckel K.H., Bauer M., Erbel R. Recall Study Investigative Group: Anklebrachial index predicts stroke in the general population in addition to classical risk factors. Atherosclerosis. 2014;233:545-50.
  16. Gutierrez J., Marshall R.S., Lazar R.M. Indirect measures of arterial stiffness and cognitive performance in individuals without traditional vascular risk factors or disease. JAMA. Neurol. 2015;72:309-15.
  17. Chen S.C., Lee W.H., Hsu P.C., Lin M.Y., lee C.S., Lin T.H., Voon W.C., Lai W.T., Sheu S.H., Su H.M. Association of Brachial-Ankle Pulse Wave Velocity With Cardiovascular Events in Atrial Fibrillation. Am. J. Hypertens. 2016;29(3): 348-56.
  18. Shirai K., Utino J., Otsuka K., et al. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI). J. Atheroscler. Thromb. 2006;13:101-7.
  19. Saji N., Sato T., Sakuta K., Aoki J., Kobayashi K., Matsumoto N., Uemura J., Shibazaki K., Kimura K. Chronic kidney disease is an independent predictor of adverse clinical outcomes in patients with recent small subcortical infarcts. Cerebrovasc. Dis. Extra. 2014;4:174-81.
  20. Shimizu Y., Nakazato M., Sekita T., Kadota K., Yamasaki H., Takamura N., Aoyagi K., Maeda T. Association of arterial stiffness and diabetes with triglycerides-to-HDL cholesterol ratio for Japanese men: The Nagasaki Islands Study. Atherosclerosis. 2013;228:491-95.
  21. Wen W., Luo R., Tang X., Tang L., Huang H.X., Wen X., Hu S., Peng B. Age-related progression of arterial stiffness and its elevated positive association with blood pressure in healthy people. Atherosclerosis. 2015;238:147-52.
  22. Милягин В.А., Милягина И.В., Пурыгина М.А. и др. Метод объемной сфигмографии на аппарате VaSera VS-1500. Методические рекомендации. Смоленск, 2014. 30.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies